Kailera Therapeutics Appoints Doug Pagán as Chief Financial Officer [Yahoo! Finance]
Alaunos Therapeutics, Inc. (TCRT)
Company Research
Source: Yahoo! Finance
WALTHAM, Mass. and SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced the appointment of Doug Pagán as its Chief Financial Officer. “Doug brings a proven ability to guide organizations through pivotal inflection points, and his financial and strategic insight will be invaluable as we scale the organization and advance our clinical-stage pipeline, including the KAI-9531 global Phase 3 program,” said Ron Renaud, President and Chief Executive Officer of Kailera. “His leadership will play a key role in supporting growth, execution and long-term value creation, and we're thrilled to welcome Doug to the Kailera team.” “I'm excited to join Kailera at this transformative stage as the company progresses its clinical programs with the potential to reshape the future of obesity care,” said Doug Pagán, Chief Financial Officer of Kailera. “I look forward to
Show less
Read more
Impact Snapshot
Event Time:
TCRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TCRT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TCRT alerts
High impacting Alaunos Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TCRT
News
- Alaunos Therapeutics (NASDAQ:TCRT) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Alaunos Therapeutics (NASDAQ:TCRT) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
TCRT
Sec Filings
- 1/15/26 - Form 4
- 1/15/26 - Form 4
- 1/15/26 - Form 4
- TCRT's page on the SEC website